GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Goldenwell Biotech Inc (OTCPK:GWLL) » Definitions » EPS (Diluted)

Goldenwell Biotech (Goldenwell Biotech) EPS (Diluted) : $0.00 (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Goldenwell Biotech EPS (Diluted)?

Goldenwell Biotech's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00.

Goldenwell Biotech's EPS (Basic) for the three months ended in Dec. 2023 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00.

Goldenwell Biotech's EPS without NRI for the three months ended in Dec. 2023 was $0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Goldenwell Biotech EPS (Diluted) Historical Data

The historical data trend for Goldenwell Biotech's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Goldenwell Biotech EPS (Diluted) Chart

Goldenwell Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
- - -0.01 -

Goldenwell Biotech Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 - - - -

Competitive Comparison of Goldenwell Biotech's EPS (Diluted)

For the Packaged Foods subindustry, Goldenwell Biotech's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Goldenwell Biotech's PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Goldenwell Biotech's PE Ratio distribution charts can be found below:

* The bar in red indicates where Goldenwell Biotech's PE Ratio falls into.



Goldenwell Biotech EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Goldenwell Biotech's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.117-0)/96.433
=-0.00

Goldenwell Biotech's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.021-0)/96.433
=-0.00

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Goldenwell Biotech  (OTCPK:GWLL) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Goldenwell Biotech EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Goldenwell Biotech's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Goldenwell Biotech (Goldenwell Biotech) Business Description

Traded in Other Exchanges
N/A
Address
2071 Midway Drive, Twinsburg, OH, USA, 44087
Goldenwell Biotech Inc is engaged in the research and development, production and sales of health care and supplements products. Its products comprise JI MAI - Bovine Cardiac Vascular Active Peptide, Double Proline AG - 3D Active Collagen Peptide, Cartilage Peptide - Type II collagen peptide, and Sugar Master.
Executives
Li Yang director, 10 percent owner, officer: Treasurer C/O GOLDENWELL BIOTECH, INC., 2071 MIDWAY DRIVE, TWINSBURG OH 44087
Hua Xie director, officer: Secretary C/O GOLDENWELL BIOTECH, INC., 2071 MIDWAY DRIVE, TWINSBURG OH 44087
Shuang Liu director, 10 percent owner, officer: Chief Executive Officer C/O GOLDENWELL BIOTECH, INC., 2071 MIDWAY DRIVE, TWINSBURG OH 44087

Goldenwell Biotech (Goldenwell Biotech) Headlines

No Headlines